Scopus Atıf Havuzu

The role of selected natural biomolecules in sperm production and functionality

A facile approach synthesis of benzoylaryl benzimidazole as potential α-amylase and α-glucosidase inhibitor with antioxidant activity

Effects of taurine on sperm quality during room temperature storage in hu sheep

New Variant with a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic Cardiomyopathy

Baseline Neutrophil-to-Lymphocyte Ratio Is Independently Associated With 90-Day Transplant-Free Mortality in Patients With Cirrhosis

Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome

Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome

Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study

COVID-19 Immunobiology: Lessons Learned, New Questions Arise

One Hundred Years of Hybrid Necrosis: Hybrid Autoimmunity as a Window into the Mechanisms and Evolution of Plant-Pathogen Interactions

Emerging technologies for conversion of sustainable algal biomass into value-added products: A state-of-the-art review

Simple and effective removal of psychiatric pharmaceuticals from wastewater treatment plant effluents by magnetite red mud nanoparticles

Hematoma Expansion Shift Analysis to Assess Acute Intracerebral Hemorrhage Treatments

Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients

The early interferon catches the SARS-CoV-2

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19